Double Medical Technology, Inc. (002901) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Double Medical Technology, Inc.

Why is Double Medical Technology, Inc. ?

The company has declared Positive results for the last 5 consecutive quarters

OPERATING CASH FLOW(Y) Highest at CNY 428.8 MM
NET SALES(9M) At CNY 1,699.51 MM has Grown at 41.82%
ROCE(HY) Highest at 12.62%

Market Beating Performance

The stock has generated a return of 42.42% in the last 1 year, much higher than market (China Shanghai Composite) returns of 15.18%

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Double Medical Technology, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Double Medical Technology, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Double Medical Technology, Inc.

46.63%

1.87

40.81%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.41%

EBIT Growth (5y)

-3.31%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.28

Sales to Capital Employed (avg)

0.50

Tax Ratio

10.39%

Dividend Payout Ratio

57.85%

Pledged Shares

Institutional Holding

ROCE (avg)

23.11%

ROE (avg)

13.80%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

5.85

EV to EBIT

39.65

EV to EBITDA

25.86

EV to Capital Employed

7.65

EV to Sales

7.46

PEG Ratio

0.15

Dividend Yield

0.95%

ROCE (Latest)

19.28%

ROE (Latest)

15.25%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

27What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 428.8 MM

NET SALES(9M)

At CNY 1,699.51 MM has Grown at 41.82%

ROCE(HY)

Highest at 12.62%

INVENTORY TURNOVER RATIO(HY)

Highest at 0.59%

DEBTORS TURNOVER RATIO(HY)

Highest at 8.12%

RAW MATERIAL COST(Y)

Fallen by -2.14% (YoY

NET PROFIT(9M)

Higher at CNY 312.36 MM

-6What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -27.36 %

INTEREST(Q)

At CNY 2.12 MM has Grown at 119.41%

OPERATING PROFIT(Q)

Lowest at CNY 101.63 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 18.73 %

Here's what is working for Double Medical Technology, Inc.

Net Profit

At CNY 216.21 MM has Grown at 1,052.6%

Year on Year (YoY)

MOJO Watch

Net Profit trend is very positive

Net Profit (CNY MM)

Net Sales

At CNY 1,141.56 MM has Grown at 38.32%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very positive

Net Sales (CNY MM)

Operating Cash Flow

Highest at CNY 428.8 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

Higher at CNY 216.21 MM

than preceding 12 month period ended Mar 2025

MOJO Watch

In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (CNY MM)

Inventory Turnover Ratio

Highest at 0.59% and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 8.12% and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -2.14% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Double Medical Technology, Inc.

Interest

At CNY 2.12 MM has Grown at 119.41%

period on period (QoQ)

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -27.36 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit

Lowest at CNY 101.63 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin

Lowest at 18.73 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales